PPA
FATE icon

Parametric Portfolio Associates’s Fate Therapeutics FATE Stock Holding History

Parametric Portfolio Associates’s Portfolio FATE Stock Details FATE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$3.02M Sell
77,774
-13,819
-15% -$535K ﹤0.01% 2182
2021
Q4 		$5.36M Buy
91,593
+5,105
+6% +$289K ﹤0.01% 1812
2021
Q3 		$5.13M Sell
86,488
-4,199
-5% -$329K ﹤0.01% 1810
2021
Q2 		$7.87M Buy
90,687
+5,910
+7% +$476K ﹤0.01% 1555
2021
Q1 		$6.99M Buy
84,777
+6,037
+8% +$578K ﹤0.01% 1935
2020
Q4 		$7.16M Buy
78,740
+17,450
+28% +$1.08M ﹤0.01% 1836
2020
Q3 		$2.45M Buy
61,290
+3,962
+7% +$138K ﹤0.01% 2383
2020
Q2 		$1.97M Sell
57,328
-3,484
-6% -$104K ﹤0.01% 2513
2020
Q1 		$1.35M Buy
60,812
+38,572
+173% +$975K ﹤0.01% 2615
2019
Q4 		$435K Buy
22,240
+2,130
+11% +$33.8K ﹤0.01% 3418
2019
Q3 		$312K Buy
20,110
+2,847
+16% +$54.6K ﹤0.01% 3510
2019
Q2 		$350K Buy
17,263
+2,763
+19% +$49.8K ﹤0.01% 3516
2019
Q1 		$255K Sell
14,500
-386
-3% -$6.09K ﹤0.01% 3622
2018
Q4 		$191K Buy
14,886
+2,697
+22% +$37.6K ﹤0.01% 3672
2018
Q3 		$199K Sell
12,189
-1,384
-10% -$16.4K ﹤0.01% 3765
2018
Q2 		$154K Sell
13,573
-81,581
-86% -$899K ﹤0.01% 3749
2018
Q1 		$929K Buy
95,154
+83,120
+691% +$796K ﹤0.01% 3060
2017
Q4 		$74K Buy
+12,034
New +$53.7K ﹤0.01% 3848

Other funds holding FATE

RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $799M AUM 253.51% 1-Year Est. Return

Parametric Portfolio Associates's FATE Position: Q1 2022 in Review

Parametric Portfolio Associates reduced its Fate Therapeutics (FATE) stake by 15% in Q1 2022, selling an estimated $535K and leaving 77,774 shares worth $3.02M. The position accounts for ﹤0.01% of the portfolio, ranked #2182.

Parametric Portfolio Associates first reported a position in FATE in Q4 2017 and has held it in 18 quarters since. The position peaked at $7.87M in Q2 2021. 250 funds tracked by Wall St. Rank hold FATE as of Q1 2022.

  • Parametric Portfolio Associates held 77,774 shares of Fate Therapeutics worth $3.02M as of Q1 2022.
  • Parametric Portfolio Associates sold 13,819 Fate Therapeutics shares in Q1 2022, an estimated $535K.
  • Fate Therapeutics made up ﹤0.01% of Parametric Portfolio Associates's portfolio in Q1 2022, its #2182 holding.
  • Parametric Portfolio Associates first reported a position in Fate Therapeutics in Q4 2017 and has held it in 18 quarters since.
  • Parametric Portfolio Associates's Fate Therapeutics position peaked at $7.87M in Q2 2021.
  • 250 funds tracked by Wall St. Rank held Fate Therapeutics as of Q1 2022.

Based on Parametric Portfolio Associates's 13F filing for Q1 2022, filed 16 May 2022.